Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06922526

Pacemaker-related Tricuspid Regurgitation Progression and Long-term Outcomes

Sponsor: Haiyan Wang

View on ClinicalTrials.gov

Summary

Tricuspid regurgitation (TR) is a common complication following cardiac implantable electronic device (CIED) implantation, with severe TR being associated with increased rates of heart failure hospitalization and all-cause mortality, significantly impairing patients' quality of life. With technological advancements, physiological pacing modalities have demonstrated superior clinical efficacy and safety profiles compared to conventional pacing methods. This study aims to evaluate predictors of adverse outcomes and TR progression in CIED recipients under different pacing modalities, thereby providing clinical guidance for high-risk patients.

Official title: Predictors of Tricuspid Regurgitation Progression and Adverse Outcomes in Different Pacing Modes

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

200

Start Date

2025-04

Completion Date

2026-05

Last Updated

2025-04-30

Healthy Volunteers

No

Interventions

DEVICE

Pacemaker implantation

Pacemaker implantation methods include right ventricular pacing, biventricular pacing, conduction system pacing

Locations (1)

The First Affiliated Hospital of Shandong First Medical University

Jinan, China